Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Ameren Corporation Launches New Stock Offering Initiative
- Vasanta Master Fund and Pagoda Push for Governance Changes
- Exciting Updates on Irpagratinib's Phase 2 Study for HCC
- AIKO's New INFINITE Modules Achieve 1GW in European Orders
- Bitcoin's Surge to $200,000: Join SIX MINING for Profits
- Explore Silver Palace: An ARPG Detective Experience Unleashed
- NeosLegal Unveils Innovative Founder's Guide for Crypto Law
- Innovative Solutions for Reducing Fruit Waste by Ugandan Duo
- Dr.AI Revolutionizes Healthcare with Innovative AI Solutions
- Jon Gosier and Southbox Entertainment Partner on The Dutchman
- Kia America's 2024 Program Achieves $4.6 Million Milestone
- NEXCOM Unveils Innovative Networking Solutions at CommunicAsia
- Sandstorm Gold Royalties Clarifies Shareholder Meeting Proposals
- BC.GAME Launches New Brand Identity with Fresh Logo and Vision
- Solaris Energy Faces Class Action: Investors May Pursue Justice
- Coastland Dental Revolutionizes Patient Care with Innovative Tech
- GI Innovation and GI Biome Achieve Milestone in Biotech Competition
- Elliott's Director Nominees Gain Support for Phillips 66's Future
- Ascot Resources Enhances Q1 Overview and Future Ambitions
- Important Settlement for Evenflo Booster Seat Consumers
- Denison Mines Focuses on Strategic Advancements and Growth
- Future of ETFs: Insights from the Latest Global Survey
- Landsea Homes Posts Strong Q1 Financial Growth and Results
- Prime Mining's Q1 2025 Highlights: Growth, Exploration Success
- Accelecom Addresses Misrepresentation by KCNA on KentuckyWired
- National Press Club Advocacy for Press Access on Air Force One
- CTS Corporation Announces Dividend Payment for Shareholders
- Carbon Done Right's Innovative Steps Towards Sustainable Growth
- Carlton Precious Initiates $1 Million Private Placement Strategy
- Samsung Galaxy S25 Edge: A Stylish Evolution on Verizon
- Natura &Co Latam Shows Remarkable Turnaround with 15% Profit
- Samarco Launches Cash Tender Offer for Senior Notes Due 2031
- Opportunity for Ibotta Investors: Lead a Class Action Lawsuit
- Natura &Co Achieves Significant Growth in Latin America Sales
- Empowering Patients: NYC's New Hospital Price Finder Tool
- Transforming Smiles: Nuvia's Vision for Dental Care Revolution
- Joe Toles Launches Musical Campaign for Foster Care Awareness
- Celebrating the Innovative Winners of Sweets & Snacks Expo
- Why Pet Companionship is Key to Our Mental Well-Being
- HighPeak Energy Delivers Strong First Quarter Financial Results
- Prospera Energy's Bold Moves: New Financing and Strategic Updates
- First Industrial Realty Trust Secures $450 Million Senior Notes
- ANI Pharmaceuticals’ Upcoming Participation in BioConnect Event
- Catheter Precision Boosts Funding with $1.5 Million Placement
- Paladin Energy Ltd Announces Interim Financial Performance Results
- Wingstop Launches Mexican Street Spice for Summer Delight
- Willow Biosciences Transforms into Atlas Energy Corp.
- G Mining Ventures Restates 2024 Financials Due to Adjustments
- Pomerantz Law Firm Pursues Investor Claims Against Aldeyra
- Somnigroup's Secondary Stock Offering: Key Details Unveiled